Endoscopic treatment of Kaposi’s sarcoma in a heart transplant patient
https://doi.org/10.15825/1995-1191-2025-1-50-54
Abstract
Kaposi’s sarcoma (KS) is a malignant tumor caused by human herpesvirus 8. Due to etiological and pathogenetic factors, this type of tumor is common among patients with immunodeficiency of various genesis. Solid organ recipients are at a high risk of developing malignant tumors in various locations due to the peculiarities of subsequent drug immunosuppressive therapy. Because KS is so common in this patient cohort, methods for early detection, efficient treatment, and prevention of the neoplastic process must be developed. This paper presents a clinical case of a successful surgical treatment of KS of the aryepiglottic fold using an endoscopic electrosurgical station with an argon complex.
About the Authors
M. T. BekovRussian Federation
Maksat Bekov
1, Shchukinskaya str., Moscow, 123182 Phone: (926) 399-49-75
I. V. Pashkov
Russian Federation
Moscow
N. P. Mozheiko
Russian Federation
Moscow
N. N. Koloskova
Russian Federation
Moscow
K. S. Smirnov
Russian Federation
Moscow
Ya. S. Yakunin
Russian Federation
Moscow
M. V. Olkhovskaya
Russian Federation
Moscow
O. M. Tsirulnikova
Russian Federation
Moscow
S. V. Gautier
Russian Federation
References
1. www.statista.com [Internet]. Estimated number of organ transplantations worldwide in 2022 [cited October 2023]. Available from: http://www.statista.com/statistics/398645/global-estimation-of-organ-transplantations.
2. Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine (Baltimore). 2002; 81 (4): 293–304. doi: 10.1097/00005792-200207000-00005.
3. Gobitti C, De Vivo F, Franchin G, Minatel E, Innocente R, Trovò MG. Kaposi’s sarcoma in a heart transplant patient. Acta Oncol. 1998; 37 (7–8): 769–770. doi: 10.1080/028418698430188.
4. Esser S, Schöfer H, Hoffmann C, Claßen J, Kreuter A, Leiter U et al. S1 Guidelines for the Kaposi Sarcoma. J Dtsch Dermatol Ges. 2022; 20 (6): 892–904. doi: 10.1111/ddg.14788.
5. Fu L, Tian T, Wang B, Lu Zh, Gao Y, Sun Y et al. Global patterns and trends in Kaposi sarcoma incidence: a population-based study. Lancet Glob Health. 2023; 11 (10): e1566–e1575. doi: 10.1016/S2214-109X(23)00349-2.
6. York C, Stratton L, Hodges J, Lei Y, Doran A. S2598 Gastric Kaposi Sarcoma Presenting as Acute Upper Gastrointestinal Hemorrhage in a Heart Transplant Patient. The American Journal of Gastroenterology. 2022; 117 (10S): e1723. doi: 10.14309/01.ajg.0000867032.40405.0a.
7. Weprin L, Zollinger R, Clausen K, Thomas FB. Kaposi’s sarcoma: endoscopic observations of gastric and colon involvement. J Clin Gastroenterol. 1982; 4 (4): 357–360.
8. Sapozhnikov AD, Perlina AD, Dymkov IN. Kaposi’s sarcoma regression after long term treatment of m-TOR inhibitors and cancellation of immunosuppressive therapy in patient after kidney transplantation. Russian Journal of Transplantology and Artificial Organs. 2019; 21 (2): 121–124. (In Russ.). https://doi.org/10.15825/1995-1191-2019-2-121-124.
Review
For citations:
Bekov M.T., Pashkov I.V., Mozheiko N.P., Koloskova N.N., Smirnov K.S., Yakunin Ya.S., Olkhovskaya M.V., Tsirulnikova O.M., Gautier S.V. Endoscopic treatment of Kaposi’s sarcoma in a heart transplant patient. Russian Journal of Transplantology and Artificial Organs. 2025;27(1):50-54. https://doi.org/10.15825/1995-1191-2025-1-50-54